The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4 <i>In Vivo</i>

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Protein</td><td class="align_center">CDOCKER RMSD</td><td class="align_center">LibDock RMSD</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">4NY9</td><td class="align_center">0.6</td><td class="align_center">6.7</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The RMSD of two modules after redock (Å).</div>

Advances in Medicine

tab2

Table 2

Table 2: The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4 <i>In Vivo</i> 

Table 2 | The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4 In Vivo 